{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:53Z","timestamp":1793814053946,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11910-021-01119-w","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:02:51Z","timestamp":1622019771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Central Nervous System Infections in Immunocompromised Patients"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3646-2448","authenticated-orcid":false,"given":"Amy A.","family":"Pruitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"issue":"2","key":"1119_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MCC.0000000000000397","volume":"23","author":"R Sonneville","year":"2017","unstructured":"\u2022\u2022 Sonneville R, Magalhaesa E, Meyfroidt G. Central nervous system infections in immunocompromised patients. Curr Opin Crit Care. 2017;23(2):128\u201333 Excellent overview of infections in groups including HIV patients.","journal-title":"Curr Opin Crit Care"},{"key":"1119_CR2","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMcpc2004996","volume":"383","author":"SS Mukerji","year":"2020","unstructured":"\u2022 Mukerji SS, Ard K, Schaefer PW, Branda JA. Case 32-2020: a 63-year-old man with confusion, fatigue, and garbled speech. N Engl J Med. 2020;383:1578\u201386 An interesting CPC discussion of novel pathogens in the context of a man who developed Borrelia miyamotoi after receipt of prednisone, cyclosporine, and 21 months of rituximab for membranous nephropathy.","journal-title":"N Engl J Med"},{"key":"1119_CR3","doi-asserted-by":"publisher","first-page":"w20377","DOI":"10.4414\/smw.2020.20377","volume":"150","author":"J Stuby","year":"2020","unstructured":"Stuby J, Herren T, Guidoc SN, Claudiad P, Alain R. Immune checkpoint inhibitor therapy-associated encephalitis: a case series and review of the literature. Swiss Med Wkly. 2020;150:w20377 Published 23 November 2020. https:\/\/doi.org\/10.4414\/smw.2020.20377.","journal-title":"Swiss Med Wkly"},{"key":"1119_CR4","doi-asserted-by":"publisher","first-page":"e2442","DOI":"10.1212\/WNL.000000000001063","volume":"95","author":"E Sechi","year":"2020","unstructured":"\u2022 Sechi E, Markovic SN, McKeon A, Duby D, et al. Neurologic autoimmunity and immune checkpoint inhibitors autoantibody profiles and outcomes. Neurology. 2020;95:e2442\u201352. https:\/\/doi.org\/10.1212\/WNL.000000000001063Discusses the newly recognized phenomena of both central and peripheral neurologic complications of ICIs and the emergence of some of the classic paraneoplastic syndromes in the presence of ICIs.","journal-title":"Neurology"},{"issue":"2","key":"1119_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24083","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014;75(2):317\u201323.","journal-title":"Ann Neurol"},{"issue":"3","key":"1119_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s1910-0150-529-1","volume":"15","author":"A Venkatesan","year":"2015","unstructured":"Venkatesan A, Benavides DR. Autoimmune encephalitis and its relation to infection. Curr Neuro Neurosci Rep. 2015;15(3):3. https:\/\/doi.org\/10.1007\/s1910-0150-529-1.","journal-title":"Curr Neuro Neurosci Rep"},{"key":"1119_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1212\/01.wnl.0000305960.85546.5f","volume":"70912","author":"JE Safdieh","year":"2008","unstructured":"Safdieh JE, Mead PA, Sepkowitz KA, et al. Bacterial and fungal meningitis in patients with cancer. Neurology. 2008;70912:943\u20137.","journal-title":"Neurology"},{"issue":"9","key":"1119_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1212\/WNL.0000000000002315","volume":"86","author":"JM Costerus","year":"2016","unstructured":"Costerus JM, Brouwer MC, Van der End A, van de Beek D. Community-acquired bacterial meningitis in aduts with cancer or a history of cancer. Neurology. 2016;86(9):860\u20136. https:\/\/doi.org\/10.1212\/WNL.0000000000002315.","journal-title":"Neurology"},{"key":"1119_CR9","doi-asserted-by":"publisher","first-page":"e13341","DOI":"10.1111\/tid.13341","volume":"22","author":"N Basic-Jukic","year":"2020","unstructured":"Basic-Jukic N, Juric I, Furic-Cunko V, Kastelani Z. Central nervous system infections in renal transplant recipients. Transpl Infect Dis. 2020;22:e13341.","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"1119_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/WCO.0000000000000686","volume":"32","author":"C Perrinjaqueta","year":"2019","unstructured":"\u2022 Perrinjaqueta C, Desbaillets N, Hottinger AF. Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy. Cur Op Neurol. 2019;32(3):500\u201310 Well-written overall review.","journal-title":"Cur Op Neurol"},{"key":"1119_CR11","doi-asserted-by":"publisher","unstructured":"Williamson PR, Jarvis JN, Panackal AA, Fisher MC et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol 2017;13 https:\/\/doi.org\/10.1038\/nrneurol.2016.167. Published online 25 Nov 2016","DOI":"10.1038\/nrneurol.2016.167"},{"key":"1119_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QCO.0000000000000404","volume":"30","author":"J Coussement","year":"2017","unstructured":"Coussement J, Lebeaux D, Rouzaud C, Lortholary O. Nocardia infections in solid organ and hematopoietic stem cell transplant recipients. Curr Opin Infect Dis. 2017;30:545\u201351.","journal-title":"Curr Opin Infect Dis"},{"key":"1119_CR13","first-page":"1378","volume":"383","author":"JD Anderson","year":"2020","unstructured":"\u2022\u2022 Anderson JD, Ho VT, Wright KT, Levy BD, Lascalzo J. Parroting lymphoma. N Engl J Med. 2020;383:1378\u201381 This is a nice clinical problem-solving case in a 48-year-old man heavily treated for EBV-positive diffuse large B cell lymphoma who presents with fever and headache.","journal-title":"N Engl J Med"},{"key":"1119_CR14","doi-asserted-by":"crossref","unstructured":"Mishra AK, Arvind VH, Muliyil D, Kuriakose CK, George AA, Karuppusami R, et al. Cerebrovascular injury in cryptococcal meningitis. Int J Stroke. 2018;13:57\u201365.","DOI":"10.1177\/1747493017706240"},{"key":"1119_CR15","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.043","volume":"28","author":"D Vela-Duarte","year":"2019","unstructured":"Vela-Duarte D, Nyberg E, Silau S, et al. Lacunar stroke in cryptococcal meningitis: clinical and radiographic features. J Stroke Cerebrovasc Dis. 2019;28:1767\u201372.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1119_CR16","doi-asserted-by":"crossref","unstructured":"Soyama A, Eguchi S, Takatsuki M, Ichikawa T, Moriuchi M, Moriuchi H, et al. Human T-cell leukemia virus type 1-associated myelopathy following living donor liver transplantation. Liver Transpl. 2008;14(5):647\u201350.","DOI":"10.1002\/lt.21414"},{"issue":"21","key":"1119_CR17","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1212\/WNL.0b013e3182752ceb","volume":"79","author":"IL Tan","year":"2012","unstructured":"Tan IL, McArthur JC, Venkatesan A, Nath A. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology. 2012;79(21):2125\u201332.","journal-title":"Neurology"},{"key":"1119_CR18","doi-asserted-by":"publisher","unstructured":"Wilson MR, O\u2019Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, et al. Chronic meningitis investigated via metagenomic next-generation sequencing. JAMA Neurol. 2018;75:947\u201355. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0463.","DOI":"10.1001\/jamaneurol.2018.0463"},{"key":"1119_CR19","unstructured":"\u2022\u2022 Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med. 2019;380:2327\u201340. This UCSF laboratory has identified unusual pathogens in undiagnosed meningitis case by finding non-human nucleic acid in CSF specimens."},{"key":"1119_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.wneu.2019.05.173","volume":"129","author":"S Ng","year":"2019","unstructured":"Ng S, Le Corre M, Aloy E, Gras-Combe G, Duffau H, Boetto J. Herpes simplex encephalitis shortly after surgery for secondary glioblastoma: a case report and review of the literature. Sep. 2019;129:13\u20137. https:\/\/doi.org\/10.1016\/j.wneu.2019.05.173.","journal-title":"Sep"},{"key":"1119_CR21","doi-asserted-by":"crossref","unstructured":"Zhao CZ, Erickson J, Dalmau J. Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology. 79:e41\u20134.","DOI":"10.1212\/WNL.0b013e3182616fad"},{"issue":"9","key":"1119_CR22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914\u201325.","journal-title":"Lancet Neurol"},{"key":"1119_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1346-8138.14074","volume":"45","author":"H Sueki","year":"2018","unstructured":"Sueki H, Mizukawa Y, Aoyama Y. Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients. J Derm. 2018;45:3\u20139.","journal-title":"J Derm"},{"issue":"2","key":"1119_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cid\/cir276","volume":"53","author":"HY Sun","year":"2011","unstructured":"Sun HY, Singh N. Opportunistic-infection immune reconstitution inflammatory syndrome in transplant recipients. Clin Infect Dis. 2011;53(2):168\u201376.","journal-title":"Clin Infect Dis"},{"key":"1119_CR25","doi-asserted-by":"publisher","unstructured":"\u2022 Kunchok A, Aksamit AJ Jr, Davis JM III, et al. Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. Published online May 18, 2020. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1162.11. An important series that highlights risk of demyelinating events with TNF-\u03b1 inhibitors exposure.","DOI":"10.1001\/jamaneurol.2020.1162.11"},{"issue":"10","key":"1119_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s12094-019-02060-8","volume":"21","author":"CR Garcia","year":"2019","unstructured":"Garcia CR, Jayswal R, Adams V, Anthony LB, Villano JL. Multiple sclerosis outcomes after cancer immunotherapy. Clin Transl Oncol. 2019;21(10):1336\u201342. https:\/\/doi.org\/10.1007\/s12094-019-02060-8.","journal-title":"Clin Transl Oncol"},{"key":"1119_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1634\/theoncologist.2016-0487","volume":"22","author":"J Larkin","year":"2017","unstructured":"\u2022\u2022 Larkin J, Chmielowski B, Lado CD, Hodi S, et al. Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis. Oncologist. 2017;22:709\u201318 The series discusses recently described syndromes and develops diagnostic strategies to distinguish autoimmune from infectious encephalitis.","journal-title":"Oncologist"},{"key":"1119_CR28","first-page":"666Y670","volume":"98","author":"DR Kaul","year":"2014","unstructured":"Kaul DR, Covington S, Taranato S, Green M, et al. Solid organ transplant donors with central nervous system infection. Transplantation. 2014;98:666Y670.","journal-title":"Transplantation"},{"issue":"9","key":"1119_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11910-013-0376-x","volume":"13","author":"BA Cohen","year":"2013","unstructured":"Cohen BA, Stosor V. Opportunistic infections of the central nervous system in the transplant patient. Curr Neurol Neursci Rep. 2013;13(9):376.","journal-title":"Curr Neurol Neursci Rep"},{"issue":"5","key":"1119_CR30","first-page":"1370","volume":"24","author":"AA Pruitt","year":"2018","unstructured":"\u2022\u2022 Pruitt AA. Infections complicating immunosuppression and transplantation. Continuum. 2018;24(5):1370\u201396 Comprehensive review with tables and case studies relevant to the subject of this review.","journal-title":"Continuum"},{"issue":"5","key":"1119_CR31","first-page":"1349","volume":"24","author":"KJ Baldwin","year":"2018","unstructured":"Baldwin KJ, Cummings CL. Herpesvirus infections of the nervous system. Continuum. 2018;24(5):1349\u201369.","journal-title":"Continuum"},{"key":"1119_CR32","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1212\/NXI.0000000000000475","volume":"5","author":"M Pawlitzki","year":"2018","unstructured":"Pawlitzki M, Teuber J, Campe C, Wagner M, Schuart C, Paul F, et al. VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab. Neurol Neuroimmunol Neuroinflamm. 2018;5:e475. https:\/\/doi.org\/10.1212\/NXI.0000000000000475.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"16","key":"1119_CR33","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1212\/WNL.0b013e31828cf8a2","volume":"80","author":"MJ Bhanushali","year":"2013","unstructured":"Bhanushali MJ, Kranick SM, Freeman AF, Cuellar-Rodriguez JM, Battiwalla M, Gea-Banacloche JC, et al. Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology. 2013;80(16):1494\u2013500.","journal-title":"Neurology"},{"key":"1119_CR34","doi-asserted-by":"publisher","unstructured":"Ueno H , Kikumto M, Takebayashi Y, Ishibashi H, et al. Pomalidomide-associated PML in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration 2020;26(3):452-455. https:\/\/doi.org\/10.1007\/s13365-020-00845-0","DOI":"10.1007\/s13365-020-00845-0"},{"key":"1119_CR35","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","volume":"380","author":"I Cortese","year":"2019","unstructured":"\u2022\u2022 Cortese I, Muranski P, Enose-Akahata Y, Ha S-K, Smith B. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. NEJM. 2019;380:1597\u2013605 Since this publication, there have been case reports and a small series of similar responses of PML to this PD-1 inhibitor.","journal-title":"NEJM"},{"issue":"6","key":"1119_CR36","first-page":"1577","volume":"21","author":"EM Williamson","year":"2015","unstructured":"Williamson EM, Berger JF. Central nervous system infections with immunomodulatory therapies. Continuum. 2015;21(6):1577\u201398.","journal-title":"Continuum"},{"issue":"2","key":"1119_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","volume":"77","author":"G Luna","year":"2020","unstructured":"\u2022\u2022 Luna G, Alping P, Burman J, Fink K, et al. Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies. JAMA Neurol. 2020;77(2):184\u201391 This study based on a nationwide register-based cohort in Sweden found that compared with interferon beta and glatiramer, the off-label use of rituximab was associated with the highest risk of serious infections (both systemic and CNS). More patients on natalizumab and fingolimod received herpes antivirals. Subclinical carryover of natalizumab explained the two cases of PML in patients with fingolimod and rituximab, respectively.","journal-title":"JAMA Neurol"},{"key":"1119_CR38","doi-asserted-by":"publisher","unstructured":"Disanto G, Ripellino P, Riccitelli GC, et al. De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis. Mult Scler. 2020. https:\/\/doi.org\/10.1177\/1352458520952036. Online ahead of print.","DOI":"10.1177\/1352458520952036"},{"key":"1119_CR39","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/jnnp-2020-323472","volume":"91","author":"CG Chisari","year":"2020","unstructured":"Chisari CG, Grimaldi LM, Salemi G, Ragonese P, Iaffaldano P, Bonavita S, et al. Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:1297\u2013303.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1119_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","volume":"12","author":"JR Berger","year":"2017","unstructured":"Berger JR. Classifying PML risk with disease modifying therapies. Mult Scler Rel Dis. 2017;12:59\u201363.","journal-title":"Mult Scler Rel Dis"},{"issue":"5","key":"1119_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/acn3.776","volume":"6","author":"D Stefoski","year":"2019","unstructured":"Stefoski D, Balabanov R, Waheed R, Ko M, et al. Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neuro. 2019;6(5):923\u201331.","journal-title":"Ann Clin Transl Neuro"},{"key":"1119_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamaneurol.2018.0368","volume":"75","author":"S Ruggieri","year":"2018","unstructured":"Ruggieri S, Logoteta A, Martini G, Bozzao A, DeGiglio L. Listeria monocytogenes\u2013induced rhombencephalitis in a patient with multiple sclerosis treated with dimethyl fumarate. JAMA Neurol. 2018;75:762\u20133.","journal-title":"JAMA Neurol"},{"key":"1119_CR43","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/WNL.0b013e3182a43b66","volume":"81","author":"K Thomas","year":"2013","unstructured":"Thomas K, Schultheiss T, Ziemssen T. Neuroborreliosis during natalizumab treatment in multiple sclerosis. Neurology. 2013;81:1012\u20133.","journal-title":"Neurology"},{"issue":"1","key":"1119_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jamaneurol.2014.3065","volume":"72","author":"AM Arvin","year":"2015","unstructured":"Arvin AM, Wolinsky JS, Kappos L, Morris MI, Reder AT, Tornatore C, et al. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol. 2015;72(1):31\u20139.","journal-title":"JAMA Neurol"},{"key":"1119_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11910-017-0800-8","volume":"17","author":"E Grebenciucova","year":"2017","unstructured":"Grebenciucova E, Pruitt A. Infections in patients receiving multiple sclerosis disease-modifying therapies. Curr Neurol Neurosci Rep. 2017;17:88.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1119_CR46","unstructured":"Center for Disease Control and Prevention (CDC): recommended adult immunization schedule, United States. 2017."},{"issue":"14","key":"1119_CR47","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1212\/WNL.0000000000010380","volume":"95","author":"A Bar-Or","year":"2020","unstructured":"Bar-Or A, Calkwood JC, Chognot C, et al. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: the VELOCE study. Neurology. 2020;95(14):1999\u20132008.","journal-title":"Neurology."},{"key":"1119_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1212\/WNL0000000000008157","volume":"93","author":"MF Farez","year":"2019","unstructured":"\u2022\u2022 Farez MF, Correale J, Armstrong MG, Rae-Grant A, et al. Practice guideline update summary: vaccine-preventable infections and immunization in multiple sclerosis. Neurology. 2019;93:584\u201394. https:\/\/doi.org\/10.1212\/WNL0000000000008157An important reference for practicing clinicians. It is hard to give definitive advice about mRNA COVID-19 vaccinations at the time of this writing (see text).","journal-title":"Neurology"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01119-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01119-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01119-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:46:55Z","timestamp":1744152415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01119-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01119-w","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"22 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"37"}}